Literature DB >> 17276034

Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity.

Ji-Yao Li1, Biao-Xin Chai, Weizhen Zhang, Yi-Qing Liu, John B Ammori, Michael W Mulholland.   

Abstract

Asb-4 is a gene that is specifically expressed in the hypothalamic energy homeostasis-associated areas and is down-regulated in the arcuate nucleus of fasted Sprague Dawley and obese Zucker rats. It has two functional domains, the ankyrin repeat and the SOCS box. The function of Asb-4 is unclear. We used yeast two hybridization to search for protein(s) that interact with Asb-4. With Asb-4 minus its SOCS box (Asb-4/Deltasb) as a bait, we screened mouse testis and arcuate nucleus cDNA libraries and identified G-protein pathway suppressor 1 (GPS1, also known as CSN1) as an Asb-4 interacting protein. GPS1 co-immunoprecipitated with Asb-4 both in vitro and in human HEK293 cells. When Asb-4 and GPS1 were co-transfected into HEK293 cells, expression of Asb-4 reduced the protein level of GPS1. Deletion of the SOCS box (Asb4/Deltasb) did not abolish the inhibitory effect of Asb-4 on GPS1, indicating that the SOCS box was not needed for its inhibitory effect. In NIH 3T3 L1 cells, expression of GPS1 enhanced c-Jun NH2-terminal kinase (JNK) activity. Co-expression of Asb-4 with GPS1 inhibited JNK activity. Treatment of the cells with insulin (20 nM) stimulated JNK activity. Expression of GPS1 potentiated the stimulatory effect of insulin, whereas co-expression of Asb-4 along with GPS1 inhibited JNK activity. In HEK293 cells expression of GPS1 elevated phosphorylation of insulin receptor substrate 1 (IRS-1) at serine307, co-expression of Asb-4 with GPS1 reduced the IRS-1ser307 phosphorylation. The present study demonstrates that Asb-4 interacts with GPS1 and inhibits JNK activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276034      PMCID: PMC2702239          DOI: 10.1016/j.cellsig.2006.12.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  34 in total

1.  NEDD8 recruits E2-ubiquitin to SCF E3 ligase.

Authors:  T Kawakami; T Chiba; T Suzuki; K Iwai; K Yamanaka; N Minato; H Suzuki; N Shimbara; Y Hidaka; F Osaka; M Omata; K Tanaka
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIRI in mediating auxin response.

Authors:  C Schwechheimer; G Serino; J Callis; W L Crosby; S Lyapina; R J Deshaies; W M Gray; M Estelle; X W Deng
Journal:  Science       Date:  2001-05-03       Impact factor: 47.728

3.  Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex.

Authors:  Andrew Wilcox; Kostas D Katsanakis; Farheen Bheda; T S Pillay
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

4.  A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3.

Authors:  M H Glickman; D M Rubin; O Coux; I Wefes; G Pfeifer; Z Cjeka; W Baumeister; V A Fried; D Finley
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

5.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

6.  Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and Asb-4.

Authors:  B T Kile; E M Viney; T A Willson; T C Brodnicki; M R Cancilla; A S Herlihy; B A Croker; M Baca; N A Nicola; D J Hilton; W S Alexander
Journal:  Gene       Date:  2000-11-27       Impact factor: 3.688

7.  The subunit 1 of the COP9 signalosome suppresses gene expression through its N-terminal domain and incorporates into the complex through the PCI domain.

Authors:  T Tsuge; M Matsui; N Wei
Journal:  J Mol Biol       Date:  2001-01-05       Impact factor: 5.469

8.  A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits.

Authors:  M Seeger; R Kraft; K Ferrell; D Bech-Otschir; R Dumdey; R Schade; C Gordon; M Naumann; W Dubiel
Journal:  FASEB J       Date:  1998-04       Impact factor: 5.191

9.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

10.  Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists.

Authors:  Tara G McDaneld; Deana L Hancock; Diane E Moody
Journal:  Physiol Genomics       Date:  2004-01-15       Impact factor: 3.107

View more
  17 in total

1.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

2.  COP9 signalosome subunits protect Capicua from MAPK-dependent and -independent mechanisms of degradation.

Authors:  Annabelle Suisse; DanQing He; Kevin Legent; Jessica E Treisman
Journal:  Development       Date:  2017-06-15       Impact factor: 6.868

3.  The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.

Authors:  Zilin Li; Shen Kiat Lim; Xu Liang; Yoon Pin Lim
Journal:  J Biol Chem       Date:  2018-11-15       Impact factor: 5.157

4.  Evidence for possible period 2 gene mediation of the effects of alcohol exposure during the postnatal period on genes associated with maintaining metabolic signaling in the mouse hypothalamus.

Authors:  Maria A Agapito; Jacklin C Barreira; Ryan W Logan; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2012-07-23       Impact factor: 3.455

5.  Variants in ASB10 are associated with open-angle glaucoma.

Authors:  Francesca Pasutto; Kate E Keller; Nicole Weisschuh; Heinrich Sticht; John R Samples; Yong-Feng Yang; Matthias Zenkel; Ursula Schlötzer-Schrehardt; Christian Y Mardin; Paolo Frezzotti; Beth Edmunds; Patricia L Kramer; Eugen Gramer; André Reis; Ted S Acott; Mary K Wirtz
Journal:  Hum Mol Genet       Date:  2011-12-08       Impact factor: 6.150

6.  Regulation of ankyrin repeat and suppressor of cytokine signalling box protein 4 expression in the immortalized murine endothelial cell lines MS1 and SVR: a role for tumour necrosis factor alpha and oxygen.

Authors:  Michael Bode; Yaxu Wu; Xinchun Pi; Pamela Lockyer; Weeranun Dechyapirom; Andrea L Portbury; Cam Patterson
Journal:  Cell Biochem Funct       Date:  2011-06       Impact factor: 3.685

Review 7.  Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology.

Authors:  Jin-Ming Tee; Maikel P Peppelenbosch
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

8.  Expression of ankyrin repeat and suppressor of cytokine signaling box protein 4 (Asb-4) in proopiomelanocortin neurons of the arcuate nucleus of mice produces a hyperphagic, lean phenotype.

Authors:  Ji-Yao Li; Biao-Xin Chai; Weizhen Zhang; Hui Wang; Michael W Mulholland
Journal:  Endocrinology       Date:  2009-11-24       Impact factor: 4.736

9.  Crystal structure and versatile functional roles of the COP9 signalosome subunit 1.

Authors:  Jung-Hoon Lee; Lina Yi; Jixi Li; Katrin Schweitzer; Marc Borgmann; Michael Naumann; Hao Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

10.  Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome.

Authors:  Brock C Christensen; E A Houseman; John J Godleski; Carmen J Marsit; Jennifer L Longacker; Cora R Roelofs; Margaret R Karagas; Margaret R Wrensch; Ru-Fang Yeh; Heather H Nelson; Joe L Wiemels; Shichun Zheng; John K Wiencke; Raphael Bueno; David J Sugarbaker; Karl T Kelsey
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.